Bruce Jackson
Stock Analyst at Benchmark
(1.11)
# 3,850
Out of 5,105 analysts
123
Total ratings
31.25%
Success rate
-16.38%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiates: Buy | $145 | $125.46 | +15.57% | 1 | Oct 10, 2025 | |
| CV CapsoVision | Initiates: Speculative Buy | $5 | $12.85 | -61.09% | 1 | Jul 28, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.81 | +238.54% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.31 | +968.70% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.74 | +304.91% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $6.77 | +387.44% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $4.33 | +431.79% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $141.32 | -43.39% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $11.85 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $101.50 | -35.96% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.27 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.23 | +381.54% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.39 | +220.51% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.17 | +156.41% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.66 | +201.20% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $9.42 | +3,084.71% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $3.52 | +1,604.55% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.67 | +2,455.24% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.15 | +1,986.96% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.35 | +1,346.34% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.41 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $24.13 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.55 | +31,272.55% | 1 | Aug 8, 2022 |
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $125.46
Upside: +15.57%
CapsoVision
Jul 28, 2025
Initiates: Speculative Buy
Price Target: $5
Current: $12.85
Upside: -61.09%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.81
Upside: +238.54%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.31
Upside: +968.70%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.74
Upside: +304.91%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $6.77
Upside: +387.44%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $4.33
Upside: +431.79%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $141.32
Upside: -43.39%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $11.85
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $101.50
Upside: -35.96%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.27
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.23
Upside: +381.54%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.39
Upside: +220.51%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.17
Upside: +156.41%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.66
Upside: +201.20%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $9.42
Upside: +3,084.71%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $3.52
Upside: +1,604.55%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.67
Upside: +2,455.24%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.15
Upside: +1,986.96%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.35
Upside: +1,346.34%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.41
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $24.13
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.55
Upside: +31,272.55%